Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

DuPont Merck research into protease inhibitors

April 5, 1996

New data, new approvals for DaunoXome

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

Alpha Leukoferon to be tested in HIV-infected hemophiliacs

March 15, 1996

Cidofovir approval recommended by committee

March 15, 1996

MDX-240 promising in HIV trials

March 15, 1996

Nagrestip tested for use in HIV

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...